Structure–function analysis and the molecular origins of anti-DNA antibodies in systemic lupus erythematosus

Patients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE or ‘lupus’) develop a wide variety of clinical and serological manifestations including the presence of antibodies to double-stranded DNA (dsDNA), which are often diagnostic and potentially pathogenic. In this review, we have examined the links between the structure and function of anti-dsDNA antibodies, emphasising their clinical associations. We have also reviewed studies involving animal models, the analysis of human antibody sequences and studies of, and using, computer modelling and crystal structure.

[1]  D. Isenberg,et al.  Properties of whole human IgG molecules produced by the expression of cloned anti-DNA antibody cDNA in mammalian cells. , 1998, Journal of autoimmunity.

[2]  D. Isenberg,et al.  Immunoglobulin variable region sequences of human monoclonal anti-DNA antibodies. , 1998, Seminars in arthritis and rheumatism.

[3]  Y. Ohsugi,et al.  IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice , 1998, Clinical and experimental immunology.

[4]  B. Hahn Antibodies to DNA. , 1998, The New England journal of medicine.

[5]  Andrew C. R. Martin,et al.  Genetic, structural and functional properties of an IgG DNA‐binding monoclonal antibody from a lupus patient with nephritis , 1998, European journal of immunology.

[6]  D. Isenberg,et al.  Anti-DNA antibodies: from gene usage to crystal structures. , 1997, Immunology today.

[7]  D. Isenberg,et al.  The role of antibodies to DNA in systemic lupus erythematosus— A review and introduction to an international workshop on DNA antibodies held in London, May 1996 , 1997, Lupus.

[8]  D. Isenberg,et al.  Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review. , 1997, British Journal of Rheumatology.

[9]  D. Isenberg,et al.  Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. , 1997, British journal of rheumatology.

[10]  J. Lecerf,et al.  Repertoire cloning of lupus anti-DNA autoantibodies. , 1996, The Journal of clinical investigation.

[11]  Andrew J. Martin,et al.  Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. , 1996, Journal of molecular biology.

[12]  D. Isenberg,et al.  An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE) , 1996, Clinical and experimental immunology.

[13]  B. Diamond,et al.  The double edged sword of the immune response: mutational analysis of a murine anti-pneumococcal, anti-DNA antibody. , 1996, The Journal of clinical investigation.

[14]  Y. Pewzner‐Jung,et al.  Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity. , 1996, Journal of immunology.

[15]  J. Thornton,et al.  Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. , 1996, Molecular immunology.

[16]  D. Isenberg,et al.  Analysis of immunoglobulin variable region genes of a human IgM anti‐myeloperoxidase antibody derived from a patient with vasculitis , 1996, Immunology.

[17]  O. Seternes,et al.  In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Isenberg,et al.  Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. , 1995, Kidney international.

[19]  B. Diamond,et al.  Cross-reactive antibodies have both protective and pathogenic potential. , 1995, Journal of immunology.

[20]  C. Kallenberg,et al.  Review : Serological markers of disease activity in systemic lupus erythematosus , 1995, Lupus.

[21]  D. Burton,et al.  Human autoantibody recognition of DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Mohan,et al.  Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. , 1995, Journal of immunology.

[23]  A R Rees,et al.  Molecular modeling of antibody-combining sites. , 1995, Methods in molecular biology.

[24]  D. Isenberg,et al.  Effect of histone and histone-RNA complexes on the disease process of murine systemic lupus erythematosus. , 1995, Autoimmunity.

[25]  S. Nagata,et al.  Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.

[26]  I. Tomlinson,et al.  The human immunoglobulin VH repertoire. , 1995, Immunology today.

[27]  J. Bach,et al.  Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. , 1994, Arthritis and rheumatism.

[28]  B. Diamond,et al.  Mutational analysis of an autoantibody: differential binding and pathogenicity , 1994, The Journal of experimental medicine.

[29]  R. Burlingame,et al.  The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. , 1994, The Journal of clinical investigation.

[30]  B. Diamond,et al.  Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Tsao,et al.  Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. , 1994, International immunology.

[32]  W. Emlen,et al.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.

[33]  C. Mol,et al.  Structure of an immunoglobulin Fab fragment specific for poly(dG).poly(dC). , 1994, The Journal of biological chemistry.

[34]  C. Mol,et al.  Structure of an immunoglobulin Fab fragment specific for triple-stranded DNA. , 1994, The Journal of biological chemistry.

[35]  A. Steinberg MRL-lpr/lpr disease: theories meet Fas. , 1994, Seminars in immunology.

[36]  R. Eisenberg,et al.  The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice. , 1994, Seminars in immunology.

[37]  R. Eisenberg,et al.  Development of the T cell receptor repertoire in lpr mice. , 1994, Seminars in immunology.

[38]  D. Isenberg,et al.  The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective. , 1994, Arthritis and rheumatism.

[39]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[40]  M. Radic,et al.  Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.

[41]  L. Schwartz,et al.  Programmed cell death, apoptosis and killer genes. , 1993, Immunology today.

[42]  D. Isenberg,et al.  Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. , 1993, Journal of autoimmunity.

[43]  B. Stollar,et al.  A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. , 1993, Journal of immunology.

[44]  J. Swindle,et al.  Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. , 1993, Journal of immunology.

[45]  D A Isenberg,et al.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.

[46]  A. Waisman,et al.  Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus , 1993, European journal of immunology.

[47]  T. Marion,et al.  Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies. , 1993, Journal of immunology.

[48]  W. Anderson,et al.  Residues that mediate DNA binding of autoimmune antibodies. , 1993, Journal of immunology.

[49]  C. Mohan,et al.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus , 1993, The Journal of experimental medicine.

[50]  R. Balderas,et al.  Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. , 1993, The Journal of clinical investigation.

[51]  D. Isenberg,et al.  Production and analysis of IgG monoclonal anti‐DNA antibodies from systemic lupus erythematosus (SLE) patients , 1993, Clinical and experimental immunology.

[52]  M. Okamura,et al.  Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. , 1993, Annals of the rheumatic diseases.

[53]  A M Lesk,et al.  Structural repertoire of the human VH segments. , 1992, Journal of molecular biology.

[54]  D. Tillman,et al.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice , 1992, The Journal of experimental medicine.

[55]  J. Kalden,et al.  Analysis of immunoglobulin variable region genes from human IgG anti‐DNA hybridomas , 1992, European journal of immunology.

[56]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[57]  M. Madaio,et al.  Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. , 1992, Journal of the American Society of Nephrology : JASN.

[58]  S. Muller,et al.  New Zealand white rabbits immunized with RNA‐complexed total histones develop an autoimmune‐like response , 1991, Clinical and experimental immunology.

[59]  D. Pisetsky,et al.  Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. , 1991, Clinical immunology and immunopathology.

[60]  T. Imanishi‐Kari,et al.  Pathogenic anti-DNA autoantibodies and pathogenic autoantibody-inducing T cells. , 1991, Immunology series.

[61]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[62]  M. Radic,et al.  Ig H and L chain contributions to autoimmune specificities. , 1991, Journal of immunology.

[63]  P. Limburg,et al.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.

[64]  D. Pisetsky,et al.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation , 1990, The Journal of experimental medicine.

[65]  A. Lesk,et al.  Conformations of immunoglobulin hypervariable regions , 1989, Nature.

[66]  A C Martin,et al.  Modeling antibody hypervariable loops: a combined algorithm. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. McCarthy,et al.  A unique sequence of the NZW I-E beta chain and its possible contribution to autoimmunity in the (NZB x NZW)F1 mouse , 1989, The Journal of experimental medicine.

[68]  D. Pisetsky,et al.  Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. , 1989, Journal of immunology.

[69]  K. Elkon,et al.  Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation. , 1988, Arthritis and rheumatism.

[70]  D. Webster,et al.  V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. , 1988, Journal of immunology.

[71]  W. Seaman,et al.  Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.

[72]  Thomas L. Rothstein,et al.  The role of clonal selection and somatic mutation in autoimmunity , 1987, Nature.

[73]  R. Pastor,et al.  A recognition site on synthetic helical oligonucleotides for monoclonal anti-native DNA autoantibody. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Jacob,et al.  Immunization of rabbits with purified RNA polymerase I induces a distinct population of antibodies against nucleic acids as well as anti-RNA polymerase I antibodies, both characteristic of systemic lupus erythematosus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[75]  A. Todd-Pokropek,et al.  Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. , 1985, Arthritis and rheumatism.

[76]  A. Edmundson,et al.  Crystallographic characterization of the Fab fragment of a monoclonal anti-ss-DNA antibody. , 1985, Molecular immunology.

[77]  R. Schwartz,et al.  Monoclonal anti‐cardiolipin antibodies bind to DNA , 1984, European journal of immunology.

[78]  S. Tonegawa Somatic generation of antibody diversity , 1983, Nature.

[79]  P. Schur,et al.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). , 1981, Medicine.

[80]  R. Schwartz,et al.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids , 1981, The Journal of experimental medicine.

[81]  R. Schwartz,et al.  Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. , 1981, Journal of immunology.

[82]  L. Aarden,et al.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[83]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.